The Catalytic Mechanism of Human Parainfluenza Virus Type 3 Haemagglutinin-Neuraminidase Revealed

Tuning Mechanism-Based Inactivators of Neuraminidases: Mechanistic and Structural Insights

(2014) Sabrina Buchini et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Exploring Human Parainfluenza Virus Type-1 Hemagglutinin–Neuraminidase as a Target for Inhibitor Discovery

(2014) Ibrahim M. El-Deeb et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors

(2014) Patrice Guillon et al.   Nature Communications

Syntheses of 2-Deoxy-2,3-didehydro-N-acetylneuraminic Acid Analogues Modified by ^|^#945;-Acylaminoamido Groups at the C-4 Position Using Isocyanide-Based Four-Component Coupling and Biological Evaluation as Inhibitors of Human Parainfluenza Virus Type 1

(2013) Reiko Nishino et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity

(2013) J.-H. Kim et al.   SCIENCE

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

(2013) Janet A. Englund et al.   VACCINE

Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors

(2013) Christopher J. Vavricka et al.   Nature Communications

Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1

(2011) Reiko Nishino et al.   BIOORGANIC & MEDICINAL CHEMISTRY

A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo

(2010) Anne Moscona et al.   JOURNAL OF INFECTIOUS DISEASES

Complexity in Influenza Virus Targeted Drug Design: Interaction with Human Sialidases

(2010) Leonard M. G. Chavas et al.   JOURNAL OF MEDICINAL CHEMISTRY

Effect of Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 on Growth and Pathogenicity of Sendai/Human Parainfluenza Type 3 Chimera Virus in Mice

(2009) M. Watanabe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice – further evaluation

(2009) Irina V Alymova et al.   ANTIVIRAL THERAPY

Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients

(2009) Richard T. Maziarz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization

(2009) Geoffrey A. Weinberg et al.   JOURNAL OF PEDIATRICS